Aer Therapeutics
Aer Therapeutics, Inc.
Aer Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative therapies targeting mucus-related issues in lung diseases. The company's primary focus is on creating inhalable treatments to address airway mucus plugs, which are common in conditions like COPD and asthma.
Products & Team
AER-01
AER-01 is a lead therapeutic candidate designed to dissolve mucus plugs in the airways of patients with severe respiratory diseases. Developed through extensive academic collaborations, it is an inhaled thiol-saccharide mucolytic agent intended to improve lung function and ease breathing difficulties.
AER-01 aims to alleviate breathing difficulties by effectively breaking down mucus plugs, thereby improving respiratory function in patients suffering from various lung diseases.
These patients commonly experience significant challenges due to airway obstruction from mucus plugs, leading to breathing difficulties and decreased quality of life.